Home-Based Exercise for Heart Failure
(MOVE-LVAD II Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Home-Based Exercise Program Using Mobile Technology for heart failure?
Research shows that home cardiac rehabilitation guided by mobile technology can improve heart function, exercise tolerance, and quality of life in heart failure patients. A study found that patients using mobile technology for home rehabilitation had better outcomes in a walking test and quality of life scores compared to those who did not use the technology.12345
Is home-based exercise safe for heart failure patients?
How is the Home-Based Exercise Program Using Mobile Technology treatment different from other treatments for heart failure?
Research Team
Himabindu Vidula, MD
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for adults over 18 who've just had a HeartMate 3 LVAD implanted and can walk on their own (even with help from a device). They must have a smartphone with internet because the exercise program uses mobile tech. It's for those going home or living at home with the LVAD within 45 days after leaving the hospital.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments including daily step measurement, six-minute walk test, frailty testing, and CT scan for muscle mass evaluation
Treatment
Participants are randomized to either the exercise intervention or usual care. The exercise group receives personalized exercise prescriptions and remote monitoring, while the usual care group is encouraged to increase walking
Follow-up
Participants are monitored for safety and effectiveness after treatment, including questionnaires, six-minute walk testing, frailty testing, and CT scans
Treatment Details
Interventions
- Home-Based Exercise Program Using Mobile Technology
Home-Based Exercise Program Using Mobile Technology is already approved in United States for the following indications:
- Improvement of physical activity and capacity in patients with HeartMate 3 LVAD
- Reduction of frailty and muscle mass loss in patients with HeartMate 3 LVAD
- Enhancement of quality of life in patients with HeartMate 3 LVAD
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator